- Home
- OGI vs PRLD Comparison
OGI vs PRLD Comparison
Compare OGI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | PRLD |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 218.0M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OGI | PRLD |
|---|---|---|
| Price | $1.40 | $4.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $5.67 |
| AVG Volume (30 Days) | ★ 754.6K | 513.4K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | $20.10 | $320.10 |
| Revenue Next Year | $13.92 | $100.00 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $1.10 | $0.75 |
| 52 Week High | $2.24 | $5.54 |
Technical Indicators
Market Signals| Indicator | OGI | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 59.73 |
| Support Level | $1.30 | $1.09 |
| Resistance Level | $1.72 | $5.54 |
| Average True Range (ATR) | 0.08 | 0.61 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 22.22 | 65.43 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.